|
CLINICAL NEWS FOR OUR PARTICIPATING HEALTH CARE PRACTITIONERS
Table of Contents
Best Practice: Peninsula Regional Medical Center's
PEARLS Program
2002 Immunization Recommendations
NCQA Validates CareFirst's Commitment to Quality
Recent Literature on Cardiovascular Disease, Cancer,
Diabetes, Asthma and Over-the-Counter Remedies
Behavioral Health: Challenges of Diagnosing Children
and Adolescents with ADHD
Recognizing ADHD Symptoms: Snap-IV Rating Scale (Adapted)
Care Management Meets Individual Health Care Needs
Care Team Disease Management Programs
Philosophy of Care
Peninsula Regional Medical Center’s PEARLS Program
The following is presented in an effort to
highlight hospital “best practice” around the region. CareFirst BlueCross
BlueShield (CareFirst) wants to share with you the innovative ways in
which Maryland, Virginia and Washington, D.C., hospitals are improving
quality of care while controlling the rising cost of health care. Look
for additional “best practice” features in future issues of HealthInk.
Named for “pearls of wisdom,” PEARLS is Peninsula Regional Medical Center’s
(PRMC’s) monthly newsletter aimed at identifying opportunities for care
efficiencies among DRGs with especially high denial rates. Created by
a subcommittee of the hospital’s Resource Management Improvement Team,
each one-page issue tackles a top denial-generating DRG by presenting
clinical guidelines, including admission criteria, outpatient care alternatives,
length of stay recommendations and documentation requirements. Now in
its fourth year, PEARLS has gained national recognition for the Salisbury,
Md., hospital.
PRMC’s Resource Management Improvement Team was designed as a much-needed
forum for a dialogue between areas like UR and Patient Care Management
looking to reconcile quality of care with denials. To determine the most
effective way to present their ideas to the hospital’s physicians, the
team surveyed doctors from all departments and was asked for a monthly,
one-page newsletter. The PEARLS committee was thereby formed and consists
of Clinical Quality Improvement Support Director Donna Thompson, R.N.,
B.S.N.; Patient Information Director Gwyn Kravec; Patient Care Management
Director Sharon Robbins; Utilization Review specialist for denials and
appeals Marygrace Ellis; PRMC hospitalist Rob Coker, D.O.; Finance representatives
as needed; and physician advisor to Patient Care Management Chris Snyder,
D.O., whose tireless championing of PEARLS to his colleagues throughout
the hospital is reportedly responsible for the program’s launch.
In its first months, the team set out to identify the hospital’s top
15 denied DRGs. Many denials were coming from strokes, so the team pulled
10 random charts to derive denial clues.
“We found that some patients were being admitted without meeting established
criteria,” says Ms. Thompson. “In other cases, medically appropriate services
were not being documented to our payors’ satisfaction.” These findings
led the PEARLS team toward compiling what they call “Points to Remember:”
brief clinical recommendations and documentation reminders for a particular
DRG focused on utilizing the most appropriate care for each patient. “Points
to Remember” are aimed at helping the hospital stay within goal length
of stay guidelines,” says Ms. Thompson. For example, PEARLS’ “Points to
Remember” on pneumonia reminds physicians that according to the American
Thoracic Society Guidelines, “… the decision to hospitalize is not necessarily
a commitment to long-term patient care. Rather, it is a decision that
certain patients should be observed closely until it is clear that their
infection is responding to therapy” and should be moved to a lower level
of care at that time.
“Points to Remember” also are aimed at encouraging accurate and complete
charting of a patient’s condition, including comorbidities, which helps
the hospital and payors alike. Documentation that adequately captures
a patient’s severity and disease complexities can better help an insurer
like CareFirst identify intervention opportunities.
Each PEARLS newsletter is a one-page overview of PRMC’s current denial
rates and length of stay compared to the state average; length of stay
and documentation guidelines from InterQual (now PEARLS’ primary review
criteria), Milliman and Robertson’s (M&R) or another widely accepted
guideline for that DRG; and “Points to Remember” compiled by the PEARLS
team.
The PEARLS team developed a newsletter for each of the 15 top-denied
DRGs in its first year-and-a-half covering DRGs like pneumonia, chest
pain and unstable angina. At the request of its doctors, PEARLS also has
addressed non-DRG topics, including compliance, blood loss anemia and
breast cancer screening and diagnosis. The PEARLS team looks for ways
to measure efficiencies in these and similar categories for which there
are no denied days. For example, MRI numbers were used in a PEARLS issue
on low back pain to help target the hospital’s high utilization of these
tests.
The team also produces PEARLS “remeasures”— a yearly progress report
on a previously covered DRG. These remeasures graph denied days improvement
data along with a “Points to Remember” refresher and any new guidelines.
The PEARLS remeasure for pneumonia, for example, illustrated PRMC’s drop
from the previous year’s 89 denied days to just 29. “Our doctors love
to see the improvements,” says Ms. Thompson.
PEARLS helped PRMC’s Patient Care Management department realize a 34
percent decrease in denial dollars over two years and has been recognized
by the Advisory Board Company of Washington, D.C., as a Top 20 innovative
idea in denials management. PRMC has sold PEARLS on CD-ROM to almost a
dozen hospitals around the country, including Johns Hopkins Bayview Medical
Center in Baltimore and St. Vincent’s Hospital in New York City (known
most recently for treating scores of victims of the Sept. 11 tragedy).
St. Vincent’s director of Case Management, Toni Cesta, Ph.D., recently
requested PRMC’s permission to reproduce a PEARLS tool in the upcoming
second edition of her book The Case Manager’s Survival Guide: Winning
Strategies for Clinical Practice.
For more information or to purchase the PEARLS program, call Donna Thompson
at 410-543-7740.
2002 Immunization Recommendations
The American Academy of Pediatrics (AAP),
the Advisory Committee on Immunization Practices (ACIP) of the Centers
for Disease Control and Prevention (CDC) and the American Academy of Family
Physicians (AAFP) issued their annual “Recommended
Childhood Immunization Schedule for 2002” earlier this year. The 2002
schedule charts the recommended time frames for routine administration
of currently licensed* vaccines for children through age 18.
*as of Dec. 1, 2001
Key Changes
No major changes have been made regarding specific vaccines since the
publication of the 2001 schedule. However, the 2002
schedule has been redesigned to depict the use of catch-up routines
for children and adolescents who fall behind or start their immunizations
late (see yellow shaded areas). The schedule also graphically emphasizes
the immunization needs of the preadolescent patient (see purple shaded
areas).
In the early 1990s, programs established to promote hepatitis B immunization
for infants and young children eventually resulted in significantly improved
immunization rates for these groups. As a result, the 2002
schedule encourages the routine use of hepatitis B vaccine for all
infants before hospital discharge to:
- Safeguard against maternal hepatitis B testing errors and testing
reporting failures.
- Protect neonates discharged to households in which hepatitis B-chronic
carriers other than the mother may reside.
- Enhance the completion of the childhood immunizations series.
Clinical Management
A May 2001 national survey indicated that only 21 percent of the responding
physicians used immunization tracking and immunization recall systems.
To help practitioners and their staff assess needed vaccinations at each
office visit (and thereby reduce missed opportunities), the 2002
schedule places children and preadolescents into identifiable categories
for quick reference.
It is important to keep in mind that during 2002, new vaccine recommendations
may be made, changes in vaccine availability may occur and other vaccine
products may be approved by the Food and Drug Administration (FDA). This
year’s recommendations also are accompanied by caveats concerning certain
vaccines in light of current national shortages. A thorough
overview of the 2002 schedule is available in the CDC’s
Morbidity and Mortality Weekly Report.
CareFirst BlueCross BlueShield (CareFirst) updates its own “Recommended
Childhood Immunization Schedule” annually to reflect any changes made
to the AAP, ACIP, CDC and AAFP schedule.
|
|
Range of Recommended Ages
|
Catch-up Vaccinations
|
Preadolescent Assessment
|
| Vaccine: |
Age: |
Birth
|
1 mo.
|
2 mos.
|
4 mos.
|
6. mos.
|
12 mos.
|
15 mos.
|
18 mos.
|
24 mos.
|
4-6 yrs.
|
11-12 yrs.
|
13-18 yrs.
|
| Hepatitis B |
Hep B #1 |
only if mother HBaAg(-)
|
|
|
|
|
|
|
|
|
|
| |
Hep B #2
|
Hep B #3
|
Hep B Series
|
| Diphtheria, Tetanus, Pertussis |
|
|
DTap |
DTaP |
DTaP |
|
DTaP
|
|
DTaP |
|
|
|
Td
|
| |
|
| H. influenzae type b |
|
|
Hib
|
Hib
|
Hib
|
Hib
|
|
|
|
|
|
| Polio |
|
|
IPV |
IPV |
IPV
|
|
IPV
|
|
|
| Measles, Mumps, Rubella |
|
|
|
|
|
MMR #1
|
|
|
MMR #2
|
|
|
|
MMR #2
|
| |
|
| Varicella |
|
|
|
|
|
Varicella
|
Varicella
|
| Pneumococcal Conjugate |
|
|
PCV |
PCV |
PCV
|
PCV
|
|
PCV*
|
PPV*
|
| Hepatitis A* |
|
|
|
|
|
|
|
|
Hepatitis A series*
|
| Influenza* |
|
|
|
|
Influenza (yearly)*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*These vaccines are recommended for selected populations
only.
Adapted from "Recommended
Childhood Immunization Schedule United States, 2002"
NCQA Validates CareFirst’s Commitment
to Quality
In January, CareFirst BlueChoice, CareFirst’s new subsidiary
HMO, and BluePreferred, a CareFirst PPO plan, received the National
Committee for Quality Assurance’s (NCQA’s) highest accreditations
following a rigorous and voluntary review process conducted in December
2001.
BlueChoice earned “Excellent” accreditation, NCQA’s highest
level of HMO accreditation. BluePreferred was granted "Full" accreditation,
the highest level for PPOs. Significant achievements for both plans, these
accreditation levels are only awarded to plans that meet or exceed NCQA’s
exacting standards and have excellent programs for continuous quality
improvement.
NCQA is an independent, not-for-profit organization dedicated
to assessing and reporting on the quality of managed care plans. The various
standards and performance measures that make up NCQA’s accreditation program
fall into the following six categories:
- Quality Improvement
- Utilization Management
- Physician Credentialing
- Members’ Rights and Responsibilities
- Preventive Health Services
- Medical Records
NCQA President Margaret E. O’Kane says “earning ‘Excellent’ accreditation
reflects a health plan’s ability to work with its members and physicians
to improve the quality of clinical care. It shows that they are building
the kinds of partnerships that are critical to delivering great care and
great service.” CareFirst BlueCross BlueShield and CareFirst BlueChoice,
Inc. extend their appreciation to all network physicians for their outstanding
quality of care and their continuing commitment to the CareFirst Quality
Improvement programs.
Recent Literature on Cardiovascular Disease,
Cancer, Diabetes, Asthma and Over-the-Counter Remedies
By T.A. Dadisman, M.D., medical director, Preventive Medicine
This article is intended to call your attention to recent information
you may have missed on management of cardiovascular
disease, cancer, diabetes
and asthma, along with some recent literature
on issues concerning over-the-counter remedies.
|
|
| What's Available: |
Where To Find It: |
|
"Approach
to Patients With Heart Failure and Normal Ejection
Fraction" discusses the diagnosis and
treatment of those patients with well-documented
signs, symptoms and radiographic evidence of heart
failure whose ejection fraction is normal (>/=
50 percent). This is the common definition of
diastolic heart failure, and numerous studies
have shown that these patients comprise 40 to
60 percent of all patients with heart failure.
A strong message contained in this review is that
aggressive control of hypertension can prevent
heart failure. (Hypertension is the most common
factor leading to diastolic heart failure.)
|
In Mayo
Clinic Proceedings (2001, 76: 047–1052).
|
|
The first article in “Guidelines for the Management of Patients
With Chronic Stable Angina” discusses diagnosis and risk stratification;
the second article discusses treatment. These articles are based
on the practice guidelines developed by the American College of
Cardiology, the American Heart Association and the American College
of Physicians — American Society of Internal Medicine and are an
excellent resource for management of these patients. One key point
made: Patient education is an important component of such management.
|
In Annals of
Internal Medicine (2001, 135: 530–547 and 616–632). You
must register to access this article online.
|
| According to “Clinical Implications of Recent Findings
From the Antihypertensive and Lipid-Lowering Treatment To Prevent
Heart Attack Trial (ALLHAT) and Other Studies of Hypertension,”
it’s not just lowering blood pressure that counts — it’s what medications
are used to do it. |
In Annals
of Internal Medicine (2001, 135: 1074–1078). You must register
to access this article online. |
| “Sound Clinical Advice for Hypertensive Patients”
is a good editorial regarding the three articles on hypertension and
its management in this issue. |
In Annals
of Internal Medicine (2001, 135: 1084–1086). You must register
to access this editorial online. |
| “Aspirin for the Primary Prevention of Cardiovascular
Events: Recommendation and Rationale” and a companion article
present the summary recommendation of the third U.S. Preventive Services
Task Force (USPSTF) for aspirin for the prevention of cardiovascular
events, as well as the supporting scientific evidence. Aspirin appears
to reduce myocardial infarction but increases gastrointestinal and
intracranial bleeding. The net effect of aspirin improves with increasing
risk for coronary heart disease. |
In Annals
of Internal Medicine (2002, 136: 157–160 and 161–172). The
full text of this article is available online under "Clinical
Guidelines". |
| “Statins
in Acute Coronary Syndromes: Start Them in the Hospital” is
a clinical review urging in-hospital start of statin therapy and discussing
the rationale for doing so. |
In the Cleveland
Clinic Journal of Medicine (2002, 69: 25–37). |
|
|
| What's Available: |
Where To Find It: |
| “Screening for Colorectal Cancer” is a Clinical Practice
department review of currently available screening methods and recommendations.
|
In The New
England Journal of Medicine (2002, 346: 40–44). Registered
users can view this article online. |
|
|
| What's Available: |
Where To Find It: |
| “American
Diabetes Association: Clinical Practice Recommendations 2002”
compiles all current ADA position statements related to clinical
practice, which form the basis for CareFirst’s diabetes clinical practice
guidelines. |
In Diabetes
Care (2002, 25: S1–S147). |
“Ramipril and the Development of Diabetes” discusses
the finding from the HOPE study that those patients who were taking
ramipril had a statistically significant lower risk of developing
diabetes than those patients assigned to
placebo. |
In The Journal of the American Medical Association
(2001, 286: 1882–1885).You can view a free abstract of this article
at:
http://jama.ama-assn.org/ v286n15
under “Brief Report” or register for access to the full text. |
| “Strategies
for Reducing Morbidity and Mortality From Diabetes Through Health-Care
System Interventions and Diabetes Self-Management Education in Community
Settings — A Report on the Recommendations of the Task Force on Community
Preventive Services.” The Task Force strongly recommends disease
management and case management to improve system-level interventions
(e.g., provider monitoring) and patient outcomes (e.g., glycemic control).
The Task Force recommends diabetes self-management education in the
home for children and adolescents with diabetes and in community gathering
places for adults. An excellent report with considerable useful information. |
In Morbidity
and Mortality Weekly Report (2001; 50, RR-16: 1–15).
|
| “Diabetes
— A Growing Public Health Concern” gives laypersons an excellent
discussion about diabetes. The message is: “Either you have it or
you don’t.” An accurate diagnosis is essential, because while a person
can live a long and healthy life with diabetes, ignoring it or not
taking it seriously can be deadly. |
In FDA
Consumer (2002, 36: 26–33). |
| “Management of Hypertension in Patients With Type
2 Diabetes Mellitus: Guidelines Based on Current Evidence.” This
article asserts that, in addition to nonpharmacologic interventions,
the first-choice antihypertensive medication should be an angiotensin-converting
enzyme inhibitor; the second and third should be a diuretic and a
ß-blocker, respectively. |
In Annals
of Internal Medicine (2001, 135: 1079–1083). You must register
to access this article online. |
| “Diabetic Foot Problems” is a thorough and
practical review in favor of aggressive prevention of the complications
that account for about one-sixth of the $44 billion the United States
spent on diabetes treatment in 1997. |
In Consultant
(2001, 41: 1693–1705). |
Over-The-Counter
Remedies
|
| What's Available: |
Where To Find It: |
|
"The Risk-Benefit Profile of Commonly Used Herbal Therapies:
Ginko, St. John Wort, Echinacea, Saw Palmetto and Kava" is
a clinically oriented overview of the efficacy and safety of these
therapies.
|
The Annals of
Internal Medicine (2001, 136:42-53). You must register to
access this article online.
|
| "What Vitamins Should I Be Taking,
Doctor?" provides useful information for counseling the 30
percent of the U.S. population who use vitamin supplements. |
In The
New England Journal of Medicine (2001, 345: 1819-1824). Registered
users can view this article online. |
Challenges of Diagnosing Children and Adolescents
With ADHD
The Three Faces of ADHD
Attention-deficit hyperactivity disorder (ADHD) is one of the most common
behavioral health diagnoses of children and yet one of the most complex.
Affecting as many as one in every 20 school-age children, this long-lasting
disorder occurs three times as often in boys as in girls until late adolescence
when the male to female ratio becomes equal.
ADHD can masquerade in three different forms. One can be viewed as the
quiet version (inattentive); another, the noisy version (hyperactive);
and the third, a mixture of symptoms. All three versions have significant
long-term consequences if not identified and treated at an early age.
Symptoms often are demonstrated by the age of 7. Girls with ADHD, as well
as both girls and boys with predominantly inattentive-only symptoms, are
prone to late or even missed diagnosis.
By recognizing the implications of the hyperactive, inattentive and
combined sets of symptoms, clinicians can play an early and critical role
in helping affected children and their families.
For some children, ADHD manifests itself as loud and disruptive outbursts,
hyperactivity with restlessness and impulsive behavior. For others, their
symptoms are much quieter: inattentiveness to detail, difficulty organizing
tasks and an inability to follow instructions. Many factors must be considered
by clinicians to make a firm diagnosis of ADHD and to recommend the best
treatment regimen for each child.
The stress ADHD can bring to families is significant and often contributes
to other difficulties within the home. Individualized treatment and teamwork
among health providers, parents and teachers can help children with ADHD
to learn, thrive and ultimately become successfully functioning adults.
Etiology
ADHD crosses all races and socioeconomic classes. Its etiology is multifactorial.
Genetics play a role, as siblings of children with ADHD are five times
more likely to develop ADHD than siblings of children in families without
ADHD. Metabolic dysfunction of the noradrenergic and dopaminergic systems
is involved. Toxic substance exposures, such as fetal exposure to tobacco
smoke during pregnancy, as well as prenatal and perinatal events, also
may play a role.
Recognizing ADHD Symptoms
Complicating the diagnostic process is the fact that up to 50 percent
of children with ADHD also have other complex disorders. These often include
oppositional defiant disorders, anxiety disorders, major depression and
learning disorders. As they grow older, a subset of children with ADHD
also is more prone to developing substance use problems. Diagnosis also
is difficult because children with ADHD may have normal or above average
intelligence, which causes them to overcompensate for their disorder.
This intelligence also can increase their frustration in coping with their
disorder. Early diagnosis of children with ADHD, however difficult, is
critical. Recognizing the inattentive and the hyperactive/impulsivity
criteria sets of the disorder will assist you in that effort.
Symptoms of ADHD With Inattention Dominant
To make a diagnosis of inattentive ADHD, six or more of the following
symptoms need to have persisted for at least six months to a degree that
is problematic and inconsistent with a child’s developmental level.
• A lack of attention to detail, demonstrated in careless mistakes in
schoolwork or other activities
• Difficulty sustaining attention in tasks or play activities
• Poor listening skills
• Difficulty in following instructions and failure to finish schoolwork
• Difficulty organizing tasks
• Forgetfulness in daily activities
• A tendency to lose things necessary for tasks
• Avoidance of tasks requiring sustained mental effort
• A tendency to be easily distracted by extraneous stimuli
Symptoms of ADHD With Hyperactivity/Impulsivity
Dominant
To make a diagnosis of hyperactive ADHD, six or more of these symptoms
need to have persisted for at least six months to a degree that is problematic
and inconsistent with a child’s developmental level.
• Frequent fidgeting or squirming while seated
• Jumping from seat when remaining seated is expected
• Running about or climbing in inappropriate places
• An inability to play quietly, alone or with others
• Excessive talking
• Impulsivity
• Blurting out answers before questions are completed
• Difficulty awaiting turn
• A tendency to interrupt or intrude on others
A rating scale based on the above criteria sets
has been adapted from the SNAP-IV (Swanson, Nolan and Pelham) Questionnaire.
This 18-item tool uses DSM-IV criteria and has demonstrated validity in
differentiating children who have ADHD from children without this disorder.
This questionnaire is to be completed by the child’s parent. The first
nine items form a subscale of inattention and the second nine form a subscale
of hyperactivity/impulsivity. A positive screen is indicated when three
or more items in either subscale are scored at two or higher and/or when
either subscale's average item score is greater than one.
Components of a Thorough Diagnosis
Because ADHD is a complex disorder, diagnosis is ideally a team process
involving the child’s school and family and often more than the child’s
primary care provider.
There are several key components to making an accurate diagnosis of ADHD:
• Thorough physical exam, including hearing and vision testing, to note
any physical illnesses or conditions that might contribute to the child’s
problems
• Careful evaluation of memory, motor, listening and speaking abilities
• Consultation with teachers regarding academic difficulties, classroom
behavior and interpersonal behavior with peers using rating scales as
one tool to standardize feedback
• Consideration of the family’s structure, physical history and any special
problems that could explain the child’s behavioral difficulties
Treatment: Diverse and Complex
Both medical and behavioral health interventions contribute to the successful
long-term treatment of ADHD. Behavioral and family therapy, with the addition
of educational aids and psychological support, can assist the ADHD child
in becoming a successfully functioning adult. These interventions also
help prevent the serious long-term problems that can develop and persist
into adulthood, including depression, substance use, employment difficulties
and relationship problems.
Medication Interventions
Stimulants are the most commonly used medications for ADHD treatment
and target the ability to focus and reduce hyperactive and/or aggressive
behavior. The ultimate goal of medication titration is finding the right
individualized dosage of medication that “normalizes” the child’s behavior.
Other agents include tricyclic antidepressants and buproprion.
Behavioral Interventions
Behavioral interventions reward “good” behavior and track this behavior
through daily cross reporting of teachers and parents on the child’s school
and home activities. Special classrooms designed to reduce extraneous
stimuli can help the child, as can special programs provided outside normal
school hours. Making sure that teachers and aides are trained in the challenges
of ADHD also will benefit the child’s performance.
Research is continuing on ADHD treatment options and the short-term vs.
long-term effectiveness of various approaches. The family, school and
health care provider team all play critical roles in a child’s successful
and continually evolving plan of care.
For More Information on ADHD
Multiple practice guidelines for the evaluation and treatment of ADHD
are available, including:
American Academy of Child & Adolescent Psychiatry Practice Parameters
for the Assessment and Treatment of Children, Adolescents and Adults With
Attention-Deficit Hyperactivity Disorder (1997)
National Institute of Mental Health Consensus Statement on Diagnosis
and Treatment of Attention-Deficit Hyperactivity Disorder (1998)
Prevalence
and Assessment of Attention-Deficit Hyperactivity Disorder in Primary
Care Settings. American Academy of Pediatrics, Pediatrics,
Vol. 107, No. 3, March 2001, pp. 1-11
Clinical Practice Guideline: Diagnosis and Evaluation of the Child With
Attention-Deficit Hyperactivity Disorder. Pediatrics, Vol. 105,
No. 5, May 2000, pp. 1158-1170
Clinical Practice Guideline: Treatment of the School-Age Child With Attention-Deficit
Hyperactivity Disorder. Pediatrics, Vol. 108, No. 4, October 2001,
pp. 1033-1044
Multimodal Treatment Study of Children With ADHD. Archives of General
Psychiatry 1999; 56 (12): 1073-1086
If you are currently treating any children or adolescents for ADHD, you
also may want to make parents aware of Web resources like www.chadd.org
and www.add.org.
SNAP-IV
RATING SCALE (ADAPTED)
Child's name ________________________________ Child's age____________________
| Inattention |
Not At All
|
Just A Little
|
Quite A Bit
|
Very Much
|
| 1. Often fails to give close attention to details or
makes careless mistakes in schoolwork or tasks |
0
|
1
|
2
|
3
|
| 2. Often has difficulty sustaining attention in tasks
or play activities |
0
|
1
|
2
|
3
|
| 3. Often does not seem to listen when spoken to directly |
0
|
1
|
2
|
3
|
| 4. Often does not follow through on instructions and
fails to finish schoolwork, chores or duties |
0
|
1
|
2
|
3
|
| 5. Often has difficulty organizing tasks and activities |
0
|
1
|
2
|
3
|
| 6. Often avoids, dislikes or reluctantly engages in
tasks requiring sustained mental effort |
0
|
1
|
2
|
3
|
| 7. Often loses things necessary for activities (e.g.
toys, school assignments, pencils or books) |
0
|
1
|
2
|
3
|
| 8. Often is distracted by extraneous stimuli |
0
|
1
|
2
|
3
|
| 9. Often is forgetful in daily activities |
0
|
1
|
2
|
3
|
| Hyperactivity/Impulsivity |
|
|
|
|
| 10. Often fidgets with hands or feet or squirms in seat |
0
|
1
|
2
|
3
|
| 11. Often leaves seat in classroom or in other situations
in which remaining seated is expected |
0
|
1
|
2
|
3
|
| 12. Often runs about or climbs excessively in situations
in which it is inappropriate |
0
|
1
|
2
|
3
|
| 13. Often has difficulty playing or engaging in leisure
activities quietly |
0
|
1
|
2
|
3
|
| 14. Often is "on the go" or often acts as
if "driven by a motor" |
0
|
1
|
2
|
3
|
| 15. Often talks excessively |
0
|
1
|
2
|
3
|
| 16. Often blurts out answers before questions have been
completed |
0
|
1
|
2
|
3
|
| 17. Often has difficulty awaiting turn |
0
|
1
|
2
|
3
|
| 18. Often interrupts or intrudes on others (e.g. butts
into conversations/games) |
0
|
1
|
2
|
3
|
Adapted from the SNAP-IV Teacher and
Parent Rating Scale
James M. Swanson, Ph.D., University of California, Irvine, CA 92715
Care Management Meets Individual Health Care
Needs
CareFirst’s Care Management program is designed to meet the individual
health care needs of patients with complex conditions using available
plan benefits. The program includes case management, which is a collaborative
process involving the patient’s physician and an assigned CareFirst case
manager (a registered nurse) who can help assess, plan, implement, coordinate,
monitor and evaluate options and services for members with complex health
care needs.
Complex cases are those that require coordination of multidisciplinary
services, monitoring and assessment. Examples include high-risk obstetrics,
neuromuscular disease, CVA, COPD, CHF, asthma, rehabilitation, wound care,
oncology and diabetes. The Care Management case manager will collaborate
with you and the rest of the patient’s health care team to ensure that
your plan of care is implemented and make certain that the member’s complex
needs are met with the necessary care. The same case manager is the lead
coordinator of special care needs and follows your patient throughout
the continuum of care, including inpatient, alternative inpatient, outpatient
and home health care settings. The case manager will contact and update
you on a regular basis. To augment the telephonic case management process,
the case manager also may visit the patient in acute or alternative settings,
at home or in your office and may attend health care team meetings as
needed. Our case managers also can assist members in finding available
community resources.
To refer a patient to Case Management, call one of the following numbers:
CareFirst BlueChoice HMO and CareFirst BlueCross BlueShield
Indemnity members:
410-605-2623 or 888-264-8648
FreeState Health Plan members: 410-605-2413 or 888-264-8648.
Care Team Disease Management Programs
Our Care Team disease management programs are designed to provide eligible
members who have asthma, diabetes, heart disease or cancer with access
to an experienced registered nurse who can help coordinate and reinforce
their plan of care, answer their questions and monitor their progress.
Participation is voluntary and confidential and is offered at no additional
cost.
Patients enrolled in our asthma, diabetes and heart disease programs
receive a packet of educational materials and regular disease-specific
newsletters aimed at helping them better understand and manage their condition.
To enroll patients who have diabetes, coronary artery disease or congestive
heart failure, call Health Management Corporation at 800-783-4582.
To enroll patients over 18 years of age who are undergoing active treatment
for cancer, call Quality Oncology at 888-245-5407.
To enroll patients who have asthma, call our Quality Improvement Department
at 800-323-4472.
Philosophy of Care
We represent a philosophy of health care that emphasizes active partnerships
between patients and their physicians. We believe that comprehensive health
care is best provided by networks of health care professionals who are
willing to be held accountable for the satisfaction of their patients
and the quality of their services. We are committed to high standards
of quality and professional ethics and to the principle that patients
come first.
We believe that patients should have the right care, at the right time
and in the right setting. This includes preventive care, as well as comprehensive
care for acute and chronic illness — at home, at the doctor’s office and
in the hospital.
We believe that all health care professionals should be held accountable
for the quality of the services they provide and for the satisfaction
of their patients.
We believe that patients should have a choice within their health plans
of physicians who meet high standards of professional training and experience,
and that informed choice and the freedom to change physicians are essential
to building active partnerships between patients and doctors.
We believe that health care decisions should be the shared responsibility
of patients, their families and health care professionals, and we encourage
physicians to share information with patients on their treatment options,
medical conditions and health status.
We believe that consumers have a right to information about health plans
and how they work. We believe that working with people to keep them healthy
is as important as making them well.
We value prevention as a key component of comprehensive care, reducing
the risks of illness and helping to treat small problems before they can
become more severe.
We believe that access to comprehensive, affordable care gives consumers
the value they expect and contributes to the peace of mind that is essential
to good health.
Adapted from the American Association of Health Plans
CareFirst’s Mission
CareFirst shall be the leading regional health care company recognized
for a comprehensive portfolio of high-quality, innovative products and
administrative services. Our purpose is to provide the best value to our
customers in partnership with the health care community and in an environment
that promotes respect, fairness and opportunity for our associates.
|